These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1075 related items for PubMed ID: 16127174

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas.
    Lakka SS, Gondi CS, Dinh DH, Olivero WC, Gujrati M, Rao VH, Sioka C, Rao JS.
    J Biol Chem; 2005 Jun 10; 280(23):21882-92. PubMed ID: 15824107
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
    Hua D, Liu MY, Cheng ZD, Qin XJ, Zhang HM, Chen Y, Qin GJ, Liang G, Li JN, Han XF, Liu DX.
    Mol Immunol; 2009 Sep 10; 46(15):2876-84. PubMed ID: 19643479
    [Abstract] [Full Text] [Related]

  • 7. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B, Nakamura M, Zhou G, Ishii A, Nakamura A, Bai Y, Mori I, Kakudo K.
    Int J Oncol; 2006 Apr 10; 28(4):807-14. PubMed ID: 16525628
    [Abstract] [Full Text] [Related]

  • 8. Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells.
    Festuccia C, Dolo V, Guerra F, Violini S, Muzi P, Pavan A, Bologna M.
    Clin Exp Metastasis; 1998 Aug 10; 16(6):513-28. PubMed ID: 9872599
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mitogen-activated protein kinase activity.
    Huang S, New L, Pan Z, Han J, Nemerow GR.
    J Biol Chem; 2000 Apr 21; 275(16):12266-72. PubMed ID: 10766865
    [Abstract] [Full Text] [Related]

  • 12. Activation of urokinase plasminogen activator and its receptor axis is essential for macrophage infiltration in a prostate cancer mouse model.
    Zhang J, Sud S, Mizutani K, Gyetko MR, Pienta KJ.
    Neoplasia; 2011 Jan 21; 13(1):23-30. PubMed ID: 21245937
    [Abstract] [Full Text] [Related]

  • 13. Radiation-inducible silencing of uPA and uPAR in vitro and in vivo in meningioma.
    Rao Gogineni V, Kumar Nalla A, Gupta R, Gorantla B, Gujrati M, Dinh DH, Rao JS.
    Int J Oncol; 2010 Apr 21; 36(4):809-16. PubMed ID: 20198323
    [Abstract] [Full Text] [Related]

  • 14. Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator.
    Jo M, Thomas KS, Marozkina N, Amin TJ, Silva CM, Parsons SJ, Gonias SL.
    J Biol Chem; 2005 Apr 29; 280(17):17449-57. PubMed ID: 15728176
    [Abstract] [Full Text] [Related]

  • 15. High level of urokinase plasminogen activator contributes to cholangiocarcinoma invasion and metastasis.
    Thummarati P, Wijitburaphat S, Prasopthum A, Menakongka A, Sripa B, Tohtong R, Suthiphongchai T.
    World J Gastroenterol; 2012 Jan 21; 18(3):244-50. PubMed ID: 22294827
    [Abstract] [Full Text] [Related]

  • 16. RNAi-mediated downregulation of urokinase plasminogen activator and its receptor in human meningioma cells inhibits tumor invasion and growth.
    Kondraganti S, Gondi CS, McCutcheon I, Dinh DH, Gujrati M, Rao JS, Olivero WC.
    Int J Oncol; 2006 Jun 21; 28(6):1353-60. PubMed ID: 16685436
    [Abstract] [Full Text] [Related]

  • 17. Inactivation of uPA and its receptor uPAR by 3,3'-diindolylmethane (DIM) leads to the inhibition of prostate cancer cell growth and migration.
    Ahmad A, Kong D, Sarkar SH, Wang Z, Banerjee S, Sarkar FH.
    J Cell Biochem; 2009 Jun 01; 107(3):516-27. PubMed ID: 19330806
    [Abstract] [Full Text] [Related]

  • 18. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug 01; 48(8):623-32. PubMed ID: 8808830
    [Abstract] [Full Text] [Related]

  • 19. Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch -1 receptor.
    Raghu H, Gondi CS, Dinh DH, Gujrati M, Rao JS.
    Mol Cancer; 2011 Oct 17; 10():130. PubMed ID: 22004682
    [Abstract] [Full Text] [Related]

  • 20. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.
    Mamoune A, Kassis J, Kharait S, Kloeker S, Manos E, Jones DA, Wells A.
    Exp Cell Res; 2004 Sep 10; 299(1):91-100. PubMed ID: 15302576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.